A practical guide to dermatological drug use in pregnancy.
Although the developing fetus was once considered protected from the outside world, we now know that it can potentially be affected by any medication given to the mother. Despite this knowledge, use of medications during pregnancy is common and pregnant women often present for treatment of dermatological disease. Therapeutic options available for these patients will be discussed.
Zip
C
C
Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification; D000075202:Contraindications; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000145:classification; D005260:Female; D047109:Fetal Development; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents; D003879:Dermatologic Agents